Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

Critical to facilitating SARS-CoV-2 point-of-care (POC) testing is assurance that viruses present in specimens are inactivated onsite prior to processing. Here, we conducted experiments to determine the virucidal activity of commercially available Viral Transport Mediums (VTMs) to inactivate SARS-CoV-2. Independent testing methods for viral inactivation testing were applied, including a previously described World Health Organization (WHO) protocol, in addition to a buffer exchange method where the virus is physically separated from the VTM post exposure. The latter method enables sensitive detection of viral viability at higher viral titre when incubated with VTM. We demonstrate that VTM formulations, Primestore® Molecular Transport Medium (MTM) and COPAN eNAT™ completely inactivate high-titre SARS-CoV-2 virus (>1 × 107 copies/mL) and are compatible with POC processing. Furthermore, full viral inactivation was rapidly achieved in as little as 2 min of VTM exposure. We conclude that adding certain VTM formulations as a first step post specimen collection will render SARS-CoV-2 non-infectious for transport, or for further in-field POC molecular testing using rapid turnaround GeneXpert platforms or equivalent.

[1]  Fayzan F. Chaudhry,et al.  SARS-CoV-2 viral load predicts COVID-19 mortality , 2020, The Lancet Respiratory Medicine.

[2]  E. Karlsson,et al.  Assessment of inactivation procedures for SARS-CoV-2 , 2020, bioRxiv.

[3]  K. Whitehead,et al.  Microbicidal actives with virucidal efficacy against SARS-CoV-2 , 2020, American Journal of Infection Control.

[4]  Shufeng Liu,et al.  Effective Heat Inactivation of SARS-CoV-2 , 2020, medRxiv.

[5]  Rahul Batra,et al.  Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation , 2020, medRxiv.

[6]  C. Cepko,et al.  SARS-CoV-2 Detection Using an Isothermal Amplification Reaction and a Rapid, Inexpensive Protocol for Sample Inactivation and Purification , 2020, medRxiv.

[7]  K. Beavis,et al.  Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays , 2020, Journal of Clinical Microbiology.

[8]  X. de Lamballerie,et al.  Evaluation of heating and chemical protocols for inactivating SARS-CoV-2 , 2020, bioRxiv.

[9]  S. Cui,et al.  Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads , 2020, Clinical chemistry.

[10]  Torsten Seemann,et al.  Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia , 2020, The Medical journal of Australia.

[11]  G. Kampf,et al.  Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols , 2020, bioRxiv.

[12]  H. Yao,et al.  Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for the COVID-19 outbreak , 2020 .

[13]  Kwok-Hung Chan,et al.  Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens , 2020, Journal of Clinical Microbiology.

[14]  J. Creswell,et al.  PrimeStore MTM and OMNIgene Sputum for the Preservation of Sputum for Xpert MTB/RIF Testing in Nigeria , 2019, Journal of clinical medicine.

[15]  C. Bruce,et al.  The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples. , 2017, Journal of virological methods.

[16]  L. May,et al.  Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu+ , 2017, Journal of Clinical Microbiology.

[17]  Sikhulile Moyo,et al.  Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable , 2016, Journal of Clinical Microbiology.

[18]  G. Fischer,et al.  Xpert(®) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  L. Daum,et al.  Real-time PCR of whole blood specimens transported in PrimeStore MTM® to detect and monitor MTB bacteremia , 2016 .

[20]  J. Druce,et al.  Evaluation of Swabs, Transport Media, and Specimen Transport Conditions for Optimal Detection of Viruses by PCR , 2011, Journal of Clinical Microbiology.

[21]  G. Fischer,et al.  A clinical specimen collection and transport medium for molecular diagnostic and genomic applications , 2010, Epidemiology and Infection.

[22]  K. Carroll,et al.  Evaluation of three Copan viral transport systems for the recovery of cultivatable, clinical virus isolates. , 2003, Diagnostic microbiology and infectious disease.

[23]  R. A. Killington,et al.  Virus isolation and quantitation , 1996, Virology Methods Manual.

[24]  Annex 4 Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products , 2003 .